Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer.

Brundage M, Danielson B, Pearcey R, Bass B, Pickles T, Bahary JP, Peng Y, Wallace D, Mackillop W.

Radiother Oncol. 2013 Jun;107(3):339-45. doi: 10.1016/j.radonc.2013.04.023. Epub 2013 Jul 2.

PMID:
23830469
2.

Quality indicators for prostate radiotherapy: are patients disadvantaged by receiving treatment in a 'generalist' centre?

Freeman AR, Roos DE, Kim L.

J Med Imaging Radiat Oncol. 2015 Apr;59(2):255-64. doi: 10.1111/1754-9485.12252. Epub 2014 Oct 27.

PMID:
25345594
3.

Quality of care indicators and their related outcomes: a population-based study in prostate cancer patients treated with radiotherapy.

Webber C, Brundage MD, Siemens DR, Groome PA.

Radiother Oncol. 2013 Jun;107(3):358-65. doi: 10.1016/j.radonc.2013.04.017. Epub 2013 May 27.

PMID:
23722081
4.

Treatment choice and quality of care for men with localized prostate cancer.

Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS.

Med Care. 2007 May;45(5):401-9.

PMID:
17446826
5.

Variations in quality of care for men with early-stage prostate cancer.

Spencer BA, Miller DC, Litwin MS, Ritchey JD, Stewart AK, Dunn RL, Gay EG, Sandler HM, Wei JT.

J Clin Oncol. 2008 Aug 1;26(22):3735-42. doi: 10.1200/JCO.2007.13.2555.

PMID:
18669460
6.

Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.

Zelefsky MJ, Moughan J, Owen J, Zietman AL, Roach M 3rd, Hanks GE.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1053-61.

PMID:
15234039
8.

Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the 1999-2001 patterns of care process survey.

Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Teshima T, Inoue T; Japanese Patterns of Care Study Working Subgroup on Prostate Cancer..

Jpn J Clin Oncol. 2004 Jan;34(1):29-36.

PMID:
15020660
9.

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation.

Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA.

Cancer. 2013 Sep 15;119(18):3265-71. doi: 10.1002/cncr.28213. Epub 2013 Jun 24.

10.

Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in Italy.

Sacerdote C, Bordon R, Pitarella S, Mano MP, Baldi I, Casella D, Di Cuonzo D, Frigerio A, Milanesio L, Merletti F, Pagano E, Ricceri F, Rosso S, Segnan N, Tomatis M, Ciccone G, Vineis P, Ponti A.

BMC Health Serv Res. 2013 Jan 25;13:28. doi: 10.1186/1472-6963-13-28.

11.

The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.

Shilkrut M, Merrick GS, McLaughlin PW, Stenmark MH, Abu-Isa E, Vance SM, Sandler HM, Feng FY, Hamstra DA.

Cancer. 2013 Feb 1;119(3):681-90. doi: 10.1002/cncr.27784. Epub 2012 Aug 14.

12.

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues.

Gaudin PB, Zelefsky MJ, Leibel SA, Fuks Z, Reuter VE.

Am J Surg Pathol. 1999 Sep;23(9):1021-31.

PMID:
10478661
13.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
14.

Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Allen Z, Adamovich E.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):32-43.

PMID:
15629591
15.

Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

Koontz BF, Chino J, Lee WR, Hahn CA, Buckley N, Huang S, Kim J, Reagan R, Joyner R, Anscher MS.

Brachytherapy. 2009 Apr-Jun;8(2):191-6. doi: 10.1016/j.brachy.2009.01.002.

PMID:
19433320
16.

Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.

Ritchey J, Gay EG, Spencer BA, Miller DC, Wallner LP, Stewart AK, Dunn RL, Litwin MS, Wei JT.

J Urol. 2012 Sep;188(3):769-74. doi: 10.1016/j.juro.2012.04.106. Epub 2012 Jul 19.

PMID:
22818140
17.
18.

Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer.

Chen RC, Rosenman JG, Hoffman LG, Chiu WK, Wang AZ, Pruthi RS, Wallen EM, Crane JM, Kim WY, Rathmell WK, Godley PA, Whang YE.

BJU Int. 2012 Dec;110(11 Pt B):E721-6. doi: 10.1111/j.1464-410X.2012.11536.x. Epub 2012 Sep 27.

19.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):25-33.

PMID:
14697417
20.

Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the Patterns of Care process survey between 1996-1998 and 1999-2001.

Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Inoue T, Teshima T; Japanese Patterns of Care Study Working Subgroup on Prostate Cancer..

Jpn J Clin Oncol. 2004 Mar;34(3):131-6.

PMID:
15078908

Supplemental Content

Support Center